A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-016-2968-z
Published Online: 2016-01-25
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Heo, Su Jin
Jung, Inkyung
Lee, Choong-kun
Kim, Jee Hung
Lim, Sun Min
Moon, Yong Wha
Shim, Hyo Sup
Jeong, Jaeheon
Kim, Joo-Hang
Kim, Hye Ryun
Cho, Byoung Chul
Text and Data Mining valid from 2016-01-25